Quality of Life Among Polish Patients with Multiple Myeloma: A Cross-Sectional Study

13 November 2025 : Clinical Research

Magdalena Kurek

^{ABCDEF 1}, Tomasz Tatara

^{ADEF 1}, Jakub Świtalski

^{CDEF 2*}, Anna Augustynowicz

^{DE 3,4}, Barbara Łopyta^{DE 5}, Mariusz Gujski

^{DE 1}, Adam Fronczak^{ADEF 6}

DOI: 10.12659/MSM.948998

Med Sci Monit 2025; 31:e948998

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 5 General characteristics of the study group and results of individual linearized coefficients.

Variable	n	Min	Max	Me	q1	q3	M	SD	SE
Global health status	246	0	100	50	33.333	58.333	48.713	15.741	1.004
Physical functioning	246	0	100	53.333	46.667	66.667	55.637	19.141	1.22
Role functioning	246	0	100	50	33.333	66.667	50.474	23.541	1.501
Emotional functioning	246	0	100	58.333	41.667	75	60.467	22.353	1.425
Cognitive functioning	246	0	100	66.667	33.333	66.667	58.943	24.215	1.544
Social functioning	246	0	100	66.667	50	83.333	65.718	23.886	1.523
Fatigue	246	0	100	66.667	44.444	66.667	59.937	22.546	1.437
Nausea and vomiting	246	0	100	50	16.667	66.667	38.889	25.747	1.642
Pain	246	0	100	50	33.333	66.667	49.458	23.612	1.505
Dyspnea	246	0	100	33.333	0	66.667	32.52	29.343	1.871
Insomnia	246	0	100	33.333	0	66.667	37.263	30.385	1.937
Appetite loss	246	0	100	66.667	33.333	66.667	54.472	31.086	1.982
Constipation	246	0	100	33.333	0	66.667	32.927	35.184	2.243
Diarrhea	246	0	100	33.333	0	66.667	35.637	36.628	2.335
Financial difficulties	246	0	100	33.333	33.333	66.667	34.553	24.896	1.587
n – sample size; Min – minimum; Max – maximum; Me – median; q1 – quartile 1; q3 – quartile 3; M – mean; SD – standard deviation; SE – standard error.

Back to the Article